Bladder Cancer Weekly

April 13, 2026

Videos

Peer-to-Peer Clinical Conversations

Perioperative Immunotherapy Versus Risk-Adapted Adjuvant Therapy in MIBC - Patrizia Giannatempo & Thomas Powles

Thomas Powles

Ashish Kamat moderates a debate between Thomas Powles and Patrizia Giannatempo on perioperative immunotherapy in muscle-invasive bladder cancer.

Bladder Preservation After Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer - Ashish Kamat

Ashish M. Kamat

Ashish Kamat discusses bladder preservation after neoadjuvant therapy with Elizabeth Plimack.

Beyond the Abstracts

Safety of Transurethral Resection of Bladder Tumor in Octogenarians: A NSQIP Analysis - Beyond the Abstract

Guidance for Avoiding Patient Pain and Discomfort During Transurethral Cystoscopy - Beyond the Abstract

Conference Coverage

EAU 2026: MIBC Systemic Therapy: Maximise Early or Strategize Post-op?

EAU 2026: Bladder Preservation Post-neoadjuvant Chemotherapy: A Smart Strategy or Risky Business?

EAU 2026: Translational Insights from CORE-008 Cohort A– Phase 2 Study of Intravesical Cretostimogene Grenadenorepvec in Patients with High-risk BCG-naïve Non-muscle Invasive Bladder Cancer.

ASCO GU 2026: Efficacy and Safety of Disitamab Vedotin Combined with Intravesical Electromotive Mitomycin-C in Patients with HER-2 Expressing High-Risk NMIBC: A Phase II Study

ASCO GU 2026: Treatment of Recurrent NMIBC with UGN-301 (Zalifrelimab) Alone and in Combination: A Phase 1 Dose Escalation Study

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

Evaluating BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis.

Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.

Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer - Beyond the Abstract

Perioperative outcomes following open radical cystectomy in the setting of locally advanced bladder cancer.

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Loss of KDM6A-Mediated Genomic Instability and Metabolic Reprogramming Regulates Response to Therapeutic Perturbations in Bladder Cancer - Beyond the Abstract

Contemporary Microhematuria Evaluation in Veterans: Cancer Detection and Resource Utilization - Beyond the Abstract

Hypoxia-Induced microRNAs confer survival advantage in bladder cancer by fine-tuning oncogenic Pathways.

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by

Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study.

Stage-independent real-time subtype classification and comprehensive biopsy profiling of urothelial carcinomas by the Lund Taxonomy system.

Role of Neoadjuvant Therapy in Histological Variant Urothelial Carcinoma.

Outcomes of Consolidative Surgery Following Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A Real-World Experience.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC